Ann: Annual Report to shareholders, page-6

No surprises and all in line. It’s just a waiting game for approvals, then watch the announcements and deals flow. Instos sitting on the sidelines will see the de-risk event and pile in. Broker coverage will follow and entry into the ASX 300, and in the blink of an eye we’ll be well over $1.

The only negative for me is receivables management needs work. More than a third are past 90 days which isn’t great for cashflow but more importantly increases the risk that those receivables could be impaired. Given we’re cashflow positive and have significant liquidity this isn’t material but it’s something I’ll be keeping an eye on.